Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) just unveiled an update.
Beijing Biostar Pharmaceuticals Co., Ltd. has announced a board meeting scheduled for August 28, 2025, to review and approve the company’s consolidated interim results for the first half of the year and consider the recommendation for an interim dividend. This meeting could impact the company’s financial strategy and provide insights into its performance and future plans, potentially affecting stakeholders’ interests.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a pharmaceutical company based in China, focusing on the development and production of biopharmaceutical products.
Average Trading Volume: 699,832
Technical Sentiment Signal: Hold
Find detailed analytics on 2563 stock on TipRanks’ Stock Analysis page.